New Drug Design Avenues Targeting Alzheimer’s Disease by Pharmacoinformatics-Aided Tools

Neurodegenerative diseases (NDD) have been of great interest to scientists for a long time due to their multifactorial character. Among these pathologies, Alzheimer’s disease (AD) is of special relevance, and despite the existence of approved drugs for its treatment, there is still no efficient phar...

Descripción completa

Detalles Bibliográficos
Autores principales: Arrué, Lily, Cigna-Méndez, Alexandra, Barbosa, Tábata, Borrego-Muñoz, Paola, Struve-Villalobos, Silvia, Oviedo, Victoria, Martínez-García, Claudia, Sepúlveda-Lara, Alexis, Millán, Natalia, Márquez Montesinos, José C. E., Muñoz, Juana, Santana, Paula A., Peña-Varas, Carlos, Barreto, George E., González, Janneth, Ramírez, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503559/
https://www.ncbi.nlm.nih.gov/pubmed/36145662
http://dx.doi.org/10.3390/pharmaceutics14091914

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503559/
https://www.ncbi.nlm.nih.gov/pubmed/36145662
http://dx.doi.org/10.3390/pharmaceutics14091914

Ejemplares similares